F. Marra
Epidemiology · 2007–2021
A researcher in the Science corpus: 5 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 64 citations into it; #743 of 2,148 by trust here, #1,026 by citations
- Molecular Biology — 55 citations into it
- Hepatology — 36 citations into it; #34 of 151 by trust here, #123 by citations
- Surgery — 24 citations into it
- Endocrinology, Diabetes and Metabolism — 15 citations into it
Whom F. Marra trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Robert Caesar
- M. Rinella
- A. Neish
- F. Bäckhed
- V. Tremaroli
- Jonathan E. Campbell
- F. Heymann
- Felix Sommer
- F. Tacke
- A. Wahlström
Who trusts F. Marra overall
Papers from F. Marra's perspective
Ordered by how strongly the researchers F. Marra trusts endorse each paper. Same corpus, a different order for every researcher.
- An obesity-associated gut microbiome with increased capacity for energy harvest (Nature)
- Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. (Cell Metabolism)
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity (Nature)
- Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation (Nature)
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH (Hepatology)
- The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis (Immunity)
- Inflammasome is a central player in the induction of obesity and insulin resistance (Proceedings of the National Academy of Sciences of the United States of America)
- NLRP6 inflammasome is a regulator of colonic microbial ecology and risk for colitis (Cell)
- TGR5-mediated bile acid sensing controls glucose homeostasis. (Cell Metabolism)
- Host-Bacterial Mutualism in the Human Intestine (Science)
Their papers
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC (2021) — 1,066 citations
- Lipotoxicity and the gut-liver axis in NASH pathogenesis. (2018) — 749 citations
- Roles for chemokines in liver disease. (2014) — 750 citations
- Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes (2009) — 629 citations
- Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis (2007) — 734 citations